Evidence map›Paper›PMID 42147366›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2026

Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer.

Juan Wang, Tianjing Chang, Lili Tang, Qingyang Li, Zhaoya Gao, Qingkun Gao, Haopeng Hong, Zhibo Hou, Wanlan Li, Yaping Li and 11 more

Abstract read
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Juan Wang *Departments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Tianjing Chang *Departments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Lili Tang *Departments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Qingyang Li *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhaoya GaoDepartment of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing 100144, China.
Qingkun GaoDepartment of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing 100144, China.
Haopeng HongDepartment of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing 100144, China.
Zhibo HouDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Wanlan LiDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Yaping LiDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Ye HanDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Wenyu WuDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Hongwei WangDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Wenhan FengDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Manli NaDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Jianjie WangDepartments of Nuclear Medicine, Peking University Shougang Hospital, Beijing 100144, China.
Mingchuan YuDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Bin ZhangDepartments of Radiology, Peking University Shougang Hospital, Beijing 100144, China.
Ming LiDepartment of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing 100144, China.
Yingshi SunKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Jin GuDepartment of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing 100144, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Although distance from the inferior tumor edge to the anal verge (DTAV) is a key predictor for sphincter-preserving surgery (SPS) in mid-low rectal cancer, its utility is limited in the "decision-gray zone" (DTAV, 3-8 cm). Therefore, this study aimed to develop and validate a multiparametric magnetic resonance imaging-based nomogram for individualized preoperative prediction of SPS feasibility. Methods: This dual-center retrospective study included 335 patients with rectal adenocarcinoma (DTAV 3-8 cm). Patients were divided into training (n=263) and external validation (n=72) cohorts, and predictors were identified using multivariate logistic regression analysis. Model discrimination was assessed using area under the receiver operating curve (AUC) and calibration via the Hosmer-Lemeshow test. Subgroup analyses were performed across DTAV strata. Results: Four independent predictors were identified: larger DTAV [odds ratio (OR) =5.00, P<0.001)], larger pubococcygeal overlap distance (PCOD) (OR=1.08, P=0.001), transverse diameter of mesorectal fat (TMS) (OR=1.07, P=0.017), and subcutaneous adipose tissue thickness (SAT) (OR=0.94, P=0.016). The Sphincter Preservation Assessment in Rectal Cancer (SPARC) nomogram achieved an AUC of 0.928 [95% confidence interval (95% CI): 0.890-0.956] in the training cohort, outperforming DTAV alone (AUC=0.884, P=0.031) and maintaining an AUC of 0.916 (95% CI: 0.827-0.969) in external validation. Subgroup analysis showed notably improved predictions in the 5-8 cm DTAV subgroup. Decision curve analysis demonstrated a pronounced net clinical benefit across a wide range of threshold probabilities. Interobserver agreement was excellent (intraclass correlation coefficient, 0.890-0.997). Conclusions: The SPARC nomogram reliably predicted SPS feasibility by integrating tumor location with pelvic anatomy and fat distribution. This provides valuable and evidence-based preoperative guidance, especially within the DTAV 3-8 cm gray zone.

Indexed as

Magnetic resonance imagingnomogrampelvimetryrectal cancersphincter preservation

Identifiers

PMID42147366
PMCPMC13171412

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.